Displaying companies
Tenvie Therapeutics is a biotechnology company founded to improve patients' lives with neurological, cardiometabolic, and ophthalmic diseases. The company is focused on developing small molecules targeting brain inflammation, metabolic dysfunction, and lysosomal issues, with a robust pipeline inherited from Denali Therapeutics. Tenvie is progressing a range of therapeutics aimed at addressing neurological, cardiometabolic, and ophthalmic conditions. Its collection of fully owned, highly brain-penetrant, and precisely designed peripherally restricted small molecules targets three main factors of disease: alleviating inflammation, correcting metabolic dysfunction, and rejuvenating lysosomal function. | San Francisco | CA | 20 - 50 | 2025 | $200,000,000 |
Ouroboros Medicines is a biotechnology company that specializes in immunology and focuses on treating long-term immune-mediated illnesses. The company addresses chronic immune-mediated conditions directly by integrating scientific knowledge, a proven history of progressing cell-depleting treatments through clinical trials, and a strong pipeline. | San Francisco | CA | 20 - 50 | 2025 | $120,000,000 |
Helicore Biopharma is at the forefront of developing cutting-edge treatments for obesity and related disorders. | 5 - 10 | 2025 | $65,000,000 | ||
GEMMABio is a therapeutics company that supports the rare disease community. | Philadelphia | PA | 50 - 100 | 2024 | $34,000,000 |
DeltaGen is an enterprise AI company transforming buyside M&A by automating 80% of manual workflows—eliminating inefficiencies and accelerating deal velocity for corporate development teams, private equity firms, and strategic acquirers. Unlike traditional AI tools that rely on manual prompting, DeltaGen’s no-prompt AI delivers highly accurate, deterministic insights with seamless integration. | 50 - 268 | 2024 | $2,700,000 | ||
Noded Ai is preparing yourself for that customer meeting is tough. Noded brings them all together using your notes history and gives you exactly what you needed , when you need it. So you’re always prepared and one step ahead. | New York | NY | 10 - 50 | 2024 | $48,000,000 |
Ply Health’s platform delivers a better and faster contracting and credentialing experience. Using our tech + automation and behavioral health expertise, we've been able to get providers in network with payers weeks to months faster than other vendors.
Ply Health partners with physical practices, digital practices, build-your-own-business platforms and new provider entrepreneurs in behavioral to magically simplify data collection, enrollment submission, follow ups and record keeping.
Ply Health is backed by YCombinator and is based in San Francisco. | San Francisco | CA | 5 - 10 | 2024 | $500,000 |
Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates to deliver best-in-class therapeutics and focused on rapidly advancing next generation transformative assets. | San Francisco | CA | 5 - 20 | 2024 | $92,000,000 |
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications. | Waltham | MA | 4 | 2024 | $602,600,000 |
AT4K specializes in and alone performs in-person autism evaluations. It is committed to reducing the time it takes for children to be evaluated for Autism Spectrum Disorder (ASD) and providing comprehensive and reliable evaluations that enable early intervention and individualized care. | Grapevine | TX | 10 - 50 | 2024 | $2,500,000 |
KALM Therapeutics provides non-steroidical treatment for eczema and psoriasis. | Huntsville | AL | 2 - 10 | 2024 | $590,380 |
Thrive AI Health builds an AI health coach. Thrive AI Health use generative AI to hyper-personalize and scale behavior change. | 10 - 50 | 2024 | $8,049,999 | ||
PilloVR is a pioneering healthtech startup dedicated to transforming pediatric healthcare through virtual reality. Our mission is to make medical visits less stressful and more engaging for young patients by using immersive VR experiences as a distraction tool during procedures such as vaccinations and blood draws. With content designed specifically for children, PilloVR helps reduce anxiety and enhance the overall patient experience while also benefiting healthcare professionals by streamlining routine procedures. Currently being tested in over 50 clinics across the U.S., including renowned institutions like Harvard, Yale, and UC Irvine, PilloVR is setting a new standard for compassionate, innovative pediatric care. | 1 - 10 | 2024 | $3,000,000 | ||
Cradle is a cryonics company that develops and proves the feasibility of human organs and whole-body reversible cryopreservation. That aims to focus on pausing and restarting biological functions through freezing to prevent tissue damage in dead bodies. | San Francisco | CA | 20 - 50 | 2024 | $48,000,000 |
Praia Health is a cutting-edge consumer platform for health systems that transforms the delivery of personalised health solutions on a large scale, allowing digital transformation. | Chicago | IL | 20 - 50 | 2024 | $20,000,000 |
World Class Health is a Hospitals and Health Care company. | New York | NY | 1 - 10 | 2024 | |
Kailera Therapeutics is a clinical-stage biotechnology company that provides revolutionary therapies for treating obesity and related diseases. | Waltham | MA | 50 - 200 | 2024 | $1,000,000,000 |
Converge Bio is at the forefront of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) specifically trained on biological languages. | Wilmington | DE | 20 - 50 | 2024 | $5,500,000 |
Astrix builds AI purchasing agents for healthcare providers. Astrix helps providers secure better deals on recurring medical supplies, equipment, and pharmacy orders by using AI to find the best offers from reputable vendors. Powered by generative AI, Astrix aggregates and normalizes data from millions of sources, delivering actionable pricing insights for buyers and sellers alike. Our team brings expertise in building AI systems from Palantir, Oxford, Duke Health, and MedStar Health. Backed by Y Combinator, Astrix operates globally from San Francisco, NYC, and London. | 2 - 10 | 2024 | $2,000,000 | ||
Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies. | 10 - 50 | 2024 | $105,000,000 | ||
Advancing healthcare through adaptable and innovative inventory management solutions. | Haddonfield | NJ | 1 - 10 | 2024 | $1,250,000 |
GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. Originally launched as BridgeBioX, a subsidiary of BridgeBio, GondolaBio secured $300M in private financing from external investors in 2024 and became an independent company within the BridgeBio ecosystem. The company aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas, including neurology, pulmonology, cardiology, nephrology, and endocrinology. Located on the Stanford Life Sciences campus, GondolaBio fosters a unique hybrid environment where top scientists from around the world collaborate with senior leadership and advisors, blending industry expertise with academic innovation. | 20 - 100 | 2024 | $300,000,000 | ||
Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients with neurodegenerative illnesses. | South San Francisco | CA | 10 - 50 | 2024 | $101,000,000 |
Jupiter Endovascular is a medical technology start-up. Its mission is to cover the entire spectrum of cardiovascular illness, seeing compelling potential to reinvent treatments for millions of people. | Menlo Park | CA | 10 - 50 | 2024 | $21,000,000 |
Responsive Arthroscopy is a medtech company that offers medical devices for the sports medicine field. | 10 - 50 | 2024 | $9,999,999 | ||
Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines. | 10 - 50 | 2024 | $93,500,000 | ||
Kabilah streamlines shift change for nurses with an AI-powered assistant that replaces paper reports. | Stanford | CA | 1 - 10 | 2024 | $500,000 |
Nura Health is a molecular diagnostics company whose mission is to advance women's health through the development and delivery of novel practice-changing non-invasive tests. We prioritize innovative, evidence-based diagnostic methods enhanced by AI & Machine Learning in order to improve clinical outcomes for complex and debilitating diseases such as endometriosis, infertility disorders, and genetic conditions that impact quality of life and longevity. | 1 - 10 | 2024 | |||
nChroma Bio's integrated product engine allows for safe, accurate, and targeted in vivo administration, addressing major shortcomings of current genetic medicine techniques. | Boston | MA | 50 - 100 | 2024 | $75,000,000 |
Chai Discovery creates Chai-1, a multi-modal foundation model designed for predicting molecular structures relevant to drug discovery. The model facilitates the unified prediction of proteins, small molecules, and nucleic acids, and is available for free for commercial applications. By enabling accurate predictions without the need for multiple sequence alignments, Chai-1 advances the capabilities of molecular modeling in the life sciences. | San Francisco | CA | 5 - 20 | 2024 | $101,000,000 |
With a mission to keep athletes active and thriving in their chosen sports for as long as possible, Eternal provides members with a holistic understanding of their health, fitness, and benchmarks for key markers of the aging process along with guidance from high-performance care teams to support every stage of an athlete’s journey. | 10 - 50 | 2024 | $13,000,000 | ||
Z-Score Health is a forward-thinking healthcare company leveraging technology to offer personalized preventive care. Their approach integrates comprehensive health risk assessments using a sophisticated SaaS platform and mobile applications, focusing on areas like women's health, geriatric care, and sexual health. They emphasize patient satisfaction and convenience, aiming to make healthcare more accessible and effective through technology. This summary provides an essence of their services and mission; for a detailed description, you would need to refer to their official website or professional profile. | Atlanta | GA | 1 - 10 | 2024 | $600,000 |
Mirador Therapeutics envisions precision medicine for immune-mediated inflammatory and fibrotic diseases. | San Diego | CA | 20 - 50 | 2024 | $480,000,000 |
Seaport Therapeutics operates as a clinical stage biopharmaceutical company. | Boston | MA | 20 - 100 | 2024 | $325,000,000 |
Coeptis Therapeutics focuses on the development and acquisition of pharmaceutical products. Coeptis’ pipeline is evolving from the partnerships being created with multiple pharmaceutical companies currently. As these relationships unfold, the product pipeline will be updated accordingly. | Wexford | PA | 5 | 2024 | $25,192,500 |
Zarminali Health is a medical organization. | Chicago | IL | 20 - 50 | 2024 | $40,000,000 |
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders. | Boulder | CO | 20 - 50 | 2024 | $41,000,000 |
Oma Care is to empower, assist, and compensate people who care for our most vulnerable citizens—family caregivers. | San Francisco | CA | 2 - 10 | 2024 | $500,000 |
Timberlyne Therapeutics is a clinical-stage biopharmaceutical company that develops and commercializes revolutionary medicines for autoimmune illnesses. The company utilizes its team's experience in drug development to secure top-tier assets focused on promising targets, and implementing them in disease areas with considerable unmet needs. | San Diego | CA | 10 - 50 | 2024 | $180,000,000 |
Rx Save Card is an innovative pharmacy benefit solution that allows businesses and employees to integrate an assortment of cost-cutting initiatives into one integrated navigation and payment experience. | Chicago | IL | 1 - 10 | 2024 | $1,700,000 |
careCycle is an AI workforce for Medicare agencies and FMOs, supporting top agencies in their operations. | 5 - 10 | 2024 | $2,000,000 | ||
Endo Health creates a gamified ''AI endocrinologist'' for type 2 diabetes management. They are creating a pleasant AI medical assistant that will walk patients through every stage of diabetic control, complete with gamified involvement. | San Francisco | CA | 1 - 10 | 2024 | $1,000,000 |
Alys Pharmaceuticals engages in immuno-dermatology services. The company is reshaping the treatment landscape through advanced scientific innovations and a strong research and development-focused multi-platform pipeline. Alys emerged as a result of the strategic aggregation of 6 asset-centric companies backed by Medicxi. | Boston | MA | 10 - 50 | 2024 | $100,000,000 |
C3 is a defense technology company developing novel solutions for medics. Built by Silent Ventures. | Ann Arbor | MI | 10 - 500 | 2024 | $55,000,000 |
Developing innovative therapeutics to materially improve the lives of patients. We strive to be transparent and open in our goals, plans, and progress. | San Diego | CA | 20 - 50 | 2024 | $370,000,000 |
Navigator Medicines operate as a biotech company that leads the advancement of biologics for targeted immune regulation & restoration. | Scotch Plains | NJ | 5 - 20 | 2024 | $100,000,000 |
K-Scale Labs is a robotic engineering company specializing in creating open-source humanoid robots. | New York | NY | 2 - 10 | 2024 | $500,000 |
Eyconis, Inc. is a privately held, pre-clinical stage biopharmaceutical company focused on transforming the ophthalmology treatment paradigm through the development, manufacture, and commercialization of novel, best-in-class therapeutics for eye diseases. The Company is advancing a pipeline of therapeutic candidates addressing areas of high unmet need including wet age-related macular degeneration (AMD). Eyconis is partnered with a syndicate of leading biopharma investors including Frazier Life Sciences, RA Capital Management, venBio Partners, and HealthQuest Capital. The Company is headquartered in Redwood City, California, including research & development laboratories with scientific and manufacturing team members. | 10 - 50 | 2024 | $85,251,248 | ||
Sonologi, Inc. is a deep-tech startup based in Palo Alto, specializing in wearable ultrasound technology for continuous real-time imaging in critical care and remote monitoring. Our patches enable non-invasive, high-resolution imaging of multiple organs simultaneously, providing comprehensive patient data for better decision-making. Sonologi focus on applications in ICU, OR, emergency care, and remote monitoring, integrating AI for advanced image analysis and diagnostics. | Palo Alto | CA | 2 - 10 | 2024 | $2,500,000 |
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research to better understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area. | San Francisco | CA | 50 - 200 | 2024 | $1,000,000,000 |
Arini is an AI receptionist for dental practices that answers phone calls, and schedules appointments. | San Francisco | CA | 1 - 10 | 2024 | $500,000 |
VisiRose offers an innovative approach to treating infectious keratitis and other eye diseases. | Knoxville | TN | 2 - 10 | 2024 | $3,000,000 |
Offcall is tackling for physician burnout by providing salary and work transparency, along with financial education. | San Francisco | CA | 5 - 20 | 2024 | $2,000,000 |
Our HIPAA-Compliant AI Assistant will save you hours of paperwork time a week. Summarize parent interviews, caregiver trainings, and RBT supervision. Automate insight extraction from client records. Generate huge parts of treatment plans.
Interested in trying it out? No credit card required. No client data needed. Sign up for free! | 1 - 10 | 2024 | |||
Trovo Health uses AI technology to provide comprehensive healthcare solutions, combining smart algorithms with professional human coaching to deliver personalized patient care. | New York | NY | 10 - 50 | 2024 | $15,000,000 |
Lift Labs is a creator of a suite of home health hardware for people living with Parkinson's Disease and Essential Tremor. Its core R&D focuses on areas of healthcare, sustainability, safety, and education. The company was founded in 2010 and is headquartered in San Francisco, California. | San Francisco | CA | 5 - 10 | 2024 | $2,900,000 |
In order to eliminate preventable death and disability from injury, trauma programs need more than a basic data repository. They need modern tools that help their entire teams do their best work. We are the most advanced trauma platform designed to help Surgeons, TPMs, Registrars, PI Coordinators and Injury Prevention Coordinators be their most effective selves. | Winter Park | FL | 10 - 50 | 2023 | $4,082,799 |
Peregrine Health is a healthcare company formed by Integrative Life Network (ILN) and Integrative Health Centers. | Nashville | TN | 20 - 50 | 2023 | $13,514,671 |
Maia Oncology is an onco-primary care clinic for cancer patients and survivors. | New York | NY | 2 - 10 | 2023 | $4,250,000 |
TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors. | Palo Alto | CA | 5 - 10 | 2023 | $6,500,000 |
Selera Medical is developing a device-based treatment for heart failure, to treat fluid overload in heart failure patients with a one-time, minimally invasive procedure | Mountain View | CA | 2 - 10 | 2023 | $500,000 |
Kenvue is a consumer health company that delivers personal health solutions. The company's brands have helped generations take care of themselves and their loved ones for more than 135 years. | Skillman | NJ | 22,000 | 2023 | $3,646,590,976 |
In-House Health is an AI-powered technical platform for modern nursing teams. | Denver | CO | 10 - 50 | 2023 | $4,000,000 |
Insighta, a landmark Joint Venture between Prenetics (NASDAQ: PRE), and renowned scientist, Prof. Dennis Lo, aims to revolutionize multi-cancer early detection. Backed by world-class science from Prof. Lo, robust capital resources of US$100m from Prenetics, and led by successful entrepreneur Danny Yeung, the joint venture is poised to transform cancer screening. Insighta plans to introduce Presight for lung and liver cancers in 2025, and to expand with Presight One for 10+ cancers in 2027. Insighta presents an unprecedented opportunity to save lives and bolster Hong Kong's standing as a global hub for life sciences innovation. | RI | 10 - 50 | 2023 | $30,000,000 | |
Clearwave operates a healthcare network that allows medical facilities to authenticate insurance eligibility of patients. | 10 - 200 | 2023 | $5,295,884 | ||
Sonia is lowering the cost of mental health treatment to a fraction of what it is now and making it available to everyone, anytime, anywhere. The App Store now features the Sonia iOS app. | New York | NY | 500 - 1,000 | 2023 | |
Founded in 2023 by a team of internationally recognized healthcare leaders, GalenusRx is revolutionizing medication safety with the power of precision. The company’s proprietary platform, APPRAISE, analyzes drug-drug, multi-drug, drug-gene, and drug-disease interactions to provide a unique and comprehensive risk assessment, individualized down to the DNA. Through the Lifesaving InsightsTM consulting service, Precision Clinical Pharmacists deliver tailored recommendations for safer, more effective drug regimens. Together, these solutions directly address polypharmacy and the potential for adverse drug events - a leading cause of death in the United States. GalenusRx’s deep data analysis also enhances the quality, safety, and efficiency of virtual clinical trials, allowing for biosimulations based on real patient data that don’t expose patients to risk. The benefits span from consumers to healthcare providers, insurers, and pharmaceutical companies, with GalenusRx’s technology leading the way toward better health outcomes and lower medical costs. | Fernandina Beach | FL | 10 - 50 | 2023 | $6,875,647 |
Sylke is a healthcare products manufacturing company that offers silk fibroin adhesive wound closure. | 20 - 50 | 2023 | $15,531,995 | ||
Nanograb is a computational drug discovery company that uses AI to generate the best combination of binders to treat different diseases. | San Francisco | CA | 5 - 10 | 2023 | $500,000 |
Fortuna streamlines Medicaid navigation for consumers, covering eligibility, enrollment, and renewal processes seamlessly. | New York | NY | 5 - 20 | 2023 | $22,000,000 |
For Henry is non-profit organization which raises funds for a child called Henry who is suffering from Alternating Hemiplegia of Childhood. | Washington, D.C. | 1 - 10 | 2023 | $2,500,000 | |
We know that drug development is both an art and a science. The work we do is incredibly technical, intentional, and specific, but there is an art to it - because we must leave room for creativity, innovation and spontaneity. Murals are paintings that transform overlooked or unused spaces - creating something impactful and meaningful. There remains many overlooked opportunities in cancer drug development. This is what inspires us. Our mission is simple, to create novel immunotherapies that can change patients’ lives so they can get back to what matters most - living. Mural Oncology is leveraging its industry-leading protein engineering platform to revolutionize cytokine-based immunotherapies for the treatment of cancer. Immunotherapies have been transformative for some people living with cancer, but unfortunately many patients still do not benefit - either because they are ineligible for treatment or they do not respond well to current therapies. We leverage our expertise in cytokine biology, immune cell modulation and our protein engineering capabilities to develop first and novel immunotherapies. Our goal is to deliver meaningful, clinical benefit across a wide range of cancers, including tumor types where immunotherapies have previously not been effective. Mural Oncology is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers. (NASDAQ: MURA) | Waltham | MA | 50 - 200 | 2023 | $275,000,000 |
Synaptrix is committed to offering free of drugs, lasting alternatives for postoperative pain treatment using NOVABLOC. | Alpharetta | GA | 2 - 10 | 2023 | $10,000,000 |
Conduce Health is an unprecedented healthcare technology company constructed to be a holistic solution for multi-specialty value-based care. | New York | NY | 10 - 50 | 2023 | $3,000,000 |
Nudge is a low-code gamification platform for consumer companies to gamify their user journeys within minutes using APIs. | San Francisco | CA | 5 - 10 | 2023 | $3,000,000 |
Andromeda Surgical is a developer of autonomous robots intended to make surgery more consistent, error-free, and efficient. | San Francisco | CA | 5 - 20 | 2023 | |
Health Harbor is a healthcare data platform designed to automate billing healthcare practices and RCM. | San Francisco | CA | 1 - 10 | 2023 | |
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness. | Laguna Hills | CA | 10 - 50 | 2023 | $10,000,000 |
Century Health accelerates drug development and commercialization by applying AI to real-world data. It is far too slow today to answer critical questions because the richest clinical data is locked away in silos. Our platform does the heavy lifting to rapidly get you the insight you need, all while supporting the research community and protecting patient privacy. | Miami | FL | 10 - 50 | 2023 | $2,000,000 |
Caire is a developer of a virtual-first care platform that puts the patient at the center. | New York | NY | 10 - 50 | 2023 | $23,100,000 |
SynsoryBio is a biotechnology research company that offers next-generation protein therapeutics services. | Somerville | MA | 1 - 10 | 2023 | $500,000 |
Biowound Solutions is a healthcare company that develops and offers treatment product for chronic wounds. | Las Vegas | NV | 1 - 10 | 2023 | $4,510,000 |
Axena Health is a women-led company dedicated to improving the lives of women with pelvic floor disorders by leveraging the power of digital technology. | Auburndale | MA | 20 - 50 | 2023 | $36,200,000 |
DANNCE is a deep learning solution to automate behavioral analysis for drug development and disease diagnosis. Our platform takes patient video as input and uses our proprietary 3-D pose tracking and behavioral analysis algorithms to quantify behavior. DANNCE will help clinicians see the unseeable and drug developers generate real world evidence by using movement data and computer vision. | Boston | MA | 5 - 10 | 2023 | $2,600,000 |
Finding the right therapist can be difficult & intimidating. Foundation makes it easy to find a more personalized therapist match, so you can focus on your care and have confidence in your therapist understanding you. Foundation offers personalized therapist matches based on personality/communication style, easy scheduling, and access to diverse and available therapists. | New York | NY | 5 - 10 | 2023 | $825,000 |
Uptiv Health provides human-centered care for people with complex needs within and beyond the four walls of a clinic setting. | Westland | MI | 5 - 20 | 2023 | $7,500,000 |
Humanaut Health operates as a company that provides health optimization and longevity. | Austin | TX | 20 - 50 | 2023 | $9,250,000 |
Savoy Life is a virtual care solution that connects long-term care operators and residents with high-quality, coordinated healthcare services. | Virginia | NE | 2 - 10 | 2023 | $3,000,000 |
Felix&Fido combines technology with operational excellence in a human-centered workplace to provide you with the best pet care possible. With multi-modal options, you never have to compromise on your pet's care. | Seattle | WA | 10 - 50 | 2023 | $4,000,000 |
Optain is a manufacturer of medical equipment and software. Optain is to make healthcare available to all people so that all can live healthy lives. Optain uses AI to create affordable clinical assistance solutions that make illness screening simple, anytime, and anywhere. | New York | NY | 10 - 50 | 2023 | $38,000,000 |
NeuroBionics is pioneering the future of precision bioelectronic medicine by inventing the next generation of implanted devices that will seamlessly interface with the human body. | Seattle | WA | 5 - 20 | 2023 | $11,000,000 |
Citizen Health is the goal was to build a platform that allowed cancer patients seamless access to their data. When Nasha joined the company in 2018 and helped evolve its focus into rare disease, it became clear that this unique approach could unlock key clinical data and build a patient community that could fundamentally shift care for patients with rare diseases while accelerating cures. | 10 - 100 | 2023 | $44,622,088 | ||
Brightstar Therapeutics is a biotechnology company focused on innovative treatment options that improve clinical outcomes and quality of life for people living with corneal and ocular surface diseases. | Lexington | KY | 5 - 10 | 2023 | |
Knownwell operates as an Artificial Intelligence as a Service platform. | Haymarket | VA | 20 - 100 | 2023 | $30,500,000 |
Vector Biomed is a state-of-the-art custom vector design and GMP manufacturing company. It is a source for safe, high-quality, reliably-manufactured Lentiviral vectors that are critical for producing gene medicines like CAR-T cell therapies and Stem Cell gene therapies. | Gaithersburg | MD | 20 - 50 | 2023 | $15,000,000 |
Gleam Care offers Self-funded health plans for companies. | San Francisco | CA | 1 - 10 | 2023 | |
Atommap is a physics-based and ML-augmented computational drug discovery platform | New York | NY | 5 - 10 | 2023 | $7,084,989 |
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease. | San Francisco | CA | 87 | 2023 | $1,100,999,936 |
twenty30 health brings a technology-enabled, patient-first and coordinated, multimodal approach to delivery of obesity care. We deliver whole-person, evidence-based interventions, with a best-in-class provider network to drive sustained weight loss and metabolic health. | Philadelphia | PA | 10 - 50 | 2023 | $5,190,000 |
ParcelBio is a company that creating a programmable method for safely and precisely delivering mRNA to many cell types in the body. | San Francisco | CA | 5 - 10 | 2023 | $500,000 |
From job listings to startups, investors to funding rounds, and everything in between, Employbl puts the power in your hands. Why wait?
Start your free trial today!Sign up for our newsletter to stay informed about the latest startups and trends in the tech market. Let Employbl be your guide to success.